Clinical Trials Directory

Trials / Completed

CompletedNCT06650150

Respiratory Muscle Strength and Exercise Capacity in Smokers

Comparative Study on Respiratory Muscle Strength and Exercise Capacity in Smokers With COPD, PRISm and Pre-COPD

Status
Completed
Phase
Study type
Observational
Enrollment
150 (actual)
Sponsor
Muğla Sıtkı Koçman University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This cross-sectional study aims to evaluate the respiratory muscle strength and physical capacity of symptomatic adult smokers in Muğla. The study population will be the patients who were admitted to the pulmonary outpatient clinic of Muğla Training and Research Hospital between July 2024 and December 2024. The primary outcome is the proportion of individuals with Maximum Inspiratory Pressure (MIP) below 80%. Secondary outcomes include the 6-Minute Walk Test (6MWT) distance, Maximum Expiratory Pressure (MEP), and COPD Assessment Test (CAT) scores. Smokers will be categorized into COPD, PRISm, and Pre-COPD groups. The study will adjust for BMI as a key confounder and assess the modifying effects of gender, smoking habits, and age. Ethical approval and informed consent will be obtained, with data analysis focusing on descriptive statistics, comparative analysis, and regression models to understand the impact of smoking on respiratory health.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTmaximal inspiratory pressuremaximal inspiratory pressure (mip) will be measured with a specific device
DIAGNOSTIC_TESTmaximal expiratory pressureMEP will be measured with a specific device
DIAGNOSTIC_TEST6 minute walk test6mwt will be done by a phsyotherapist

Timeline

Start date
2024-10-20
Primary completion
2025-07-20
Completion
2025-07-20
First posted
2024-10-21
Last updated
2025-08-08

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06650150. Inclusion in this directory is not an endorsement.